Adagene Inc (ADAG)
2.68
-0.13
(-4.63%)
USD |
NASDAQ |
Jun 14, 16:00
2.66
-0.02
(-0.75%)
Pre-Market: 20:00
Adagene Total Liabilities (Quarterly): 45.17M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.17M |
| June 30, 2023 | 52.51M |
| December 31, 2022 | 69.31M |
| June 30, 2022 | 65.87M |
| December 31, 2021 | 32.95M |
| Date | Value |
|---|---|
| June 30, 2021 | 31.64M |
| December 31, 2020 | 173.65M |
| September 30, 2020 | 13.61M |
| December 31, 2019 | 162.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.61M
Minimum
Sep 2020
173.65M
Maximum
Dec 2020
71.96M
Average
52.51M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 42.54M |
| Zai Lab Ltd | 226.27M |
| China SXT Pharmaceuticals Inc | 9.512M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.73M |
| Shareholders Equity (Quarterly) | 70.56M |
| Debt to Equity Ratio | 0.3109 |
| Current Ratio | 3.606 |
| Net Debt Paydown Yield | -2.10% |